The rationale and importance of antihyperglycaemic treatment: J.E. Fradkin, USA; A. Tsapas, Greece
Personalised approach based on patient characteristics and comorbidities: P. Rossing, DK
Therapeutic options: lifestyle management and pharmacologic treatment: W.N. Kernan, USA; G. Mingrone, Italy
Strategies for implementing antihyperglycaemic treatment plan: D.A. D’Alessio, USA; C. Mathieu, Belgium
Key knowledge gaps: J.B. Buse, USA
Summary and implications from the EAsD/ADA perspective: D.R. Matthews, UK; W.T. Cefalu, USA
Todos os direitos reservados